IL97936A - History of 4-Transformed-2-Deoxy-2, 3-Didhydro of D-Neuramic Acid, their Preparation and Pharmaceutical Preparations Containing Them - Google Patents

History of 4-Transformed-2-Deoxy-2, 3-Didhydro of D-Neuramic Acid, their Preparation and Pharmaceutical Preparations Containing Them

Info

Publication number
IL97936A
IL97936A IL9793691A IL9793691A IL97936A IL 97936 A IL97936 A IL 97936A IL 9793691 A IL9793691 A IL 9793691A IL 9793691 A IL9793691 A IL 9793691A IL 97936 A IL97936 A IL 97936A
Authority
IL
Israel
Prior art keywords
compound
acetamido
glycero
galacto
tetradeoxy
Prior art date
Application number
IL9793691A
Other languages
English (en)
Hebrew (he)
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management filed Critical Biota Scient Management
Publication of IL97936A publication Critical patent/IL97936A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL9793691A 1990-04-24 1991-04-24 History of 4-Transformed-2-Deoxy-2, 3-Didhydro of D-Neuramic Acid, their Preparation and Pharmaceutical Preparations Containing Them IL97936A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPJ980090 1990-04-24
AUPK289690 1990-10-19
AUPK453791 1991-02-11

Publications (1)

Publication Number Publication Date
IL97936A true IL97936A (en) 1995-12-08

Family

ID=27157556

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9793691A IL97936A (en) 1990-04-24 1991-04-24 History of 4-Transformed-2-Deoxy-2, 3-Didhydro of D-Neuramic Acid, their Preparation and Pharmaceutical Preparations Containing Them

Country Status (37)

Country Link
US (2) US5360817A (sv)
EP (2) EP0526543B1 (sv)
JP (1) JP2944750B2 (sv)
KR (1) KR0169496B1 (sv)
CN (3) CN1143853C (sv)
AP (1) AP249A (sv)
AT (2) ATE161253T1 (sv)
AU (2) AU654815B2 (sv)
BG (1) BG62092B1 (sv)
CA (2) CA2291994C (sv)
CY (1) CY2186B1 (sv)
CZ (1) CZ288492B6 (sv)
DE (3) DE69128469T2 (sv)
DK (1) DK0526543T3 (sv)
ES (2) ES2313730T3 (sv)
FI (2) FI105478B (sv)
GR (1) GR3026225T3 (sv)
HK (2) HK1003834A1 (sv)
HU (2) HU219355B (sv)
IE (2) IE980526A1 (sv)
IL (1) IL97936A (sv)
LU (1) LU90468I2 (sv)
MY (1) MY107843A (sv)
NL (1) NL990030I2 (sv)
NO (3) NO302751B1 (sv)
NZ (1) NZ237936A (sv)
OA (1) OA09679A (sv)
PL (3) PL166918B1 (sv)
PT (1) PT97460B (sv)
RU (1) RU2119487C1 (sv)
SG (1) SG43170A1 (sv)
SI (1) SI9110745B (sv)
SK (1) SK282950B6 (sv)
UA (1) UA41252C2 (sv)
WO (1) WO1991016320A1 (sv)
YU (1) YU48741B (sv)
ZA (1) ZA913086B (sv)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
US5958973A (en) * 1993-09-03 1999-09-28 Gilead Sciences, Inc. Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
GB9325841D0 (en) 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
AU687197B2 (en) * 1994-05-27 1998-02-19 Daikin Industries, Ltd. 7-fluoro-2, 3-didehydrosialic acid and intermediate for synthesis thereof
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
US5475109A (en) * 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
AU4259500A (en) * 1995-02-27 2000-08-31 Gilead Sciences, Inc. Novel compounds and methods for synthesis and therapy
CN100338031C (zh) * 1995-02-27 2007-09-19 吉里德科学公司 新颖化合物，其合成方法及治疗用途
HU229200B1 (en) * 1995-02-27 2013-09-30 Gilead Sciences Inc Selective inhibitors of viral or bacterial neuraminidase
AU720933B2 (en) * 1995-02-27 2000-06-15 Gilead Sciences, Inc. Novel selective inhibitors of viral or bacterial neuraminidases
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
EP0833825B1 (en) * 1995-05-19 2001-09-26 Biota Scientific Management Pty. Ltd. 6-carboxamido dihydropyran derivatives
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
JPH0967270A (ja) * 1995-08-31 1997-03-11 Res Dev Corp Of Japan 水晶体混濁の予防および治療法、並びにそのための薬 剤
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
NZ331189A (en) 1996-03-01 1999-06-29 Biota Scient Management Method of detection of influenza virus using neuraminidase binders
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
PT823428E (pt) * 1996-07-22 2002-04-29 Sankyo Co Derivados do acido neuraminico sua preparacao e sua utilizacao em medicina
CA2263336C (en) * 1996-08-13 2007-03-13 Sankyo Company, Limited Neuraminic acid compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
EP0882721A4 (en) * 1996-09-10 1999-12-22 Daikin Ind Ltd 4-SUBSTITUTED 2,7-DIDEOXY-7-FLUORO-2,3-DIDEHYDRO SIAL ACIDS
US5719020A (en) * 1996-09-25 1998-02-17 Oklahoma Medical Research Foundation 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
JP2001502690A (ja) * 1996-10-21 2001-02-27 ギリアード サイエンシーズ，インコーポレイテッド ピペリジン化合物
CN1238783A (zh) 1996-11-14 1999-12-15 百奥塔科学管理有限公司 方法及其所用的新化合物
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
JP3390965B2 (ja) 1997-09-12 2003-03-31 理化学研究所 糖結合スフィンゴシンを含有するポリマー化合物
NZ502988A (en) * 1997-09-17 2002-08-28 Gilead Sciences Inc 5-Acetamido-4-amino-2-propionyloxy-6-isopropoxy-1-cyclohexene useful for treating influenza
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
WO1999054290A1 (en) * 1998-04-23 1999-10-28 Abbott Laboratories Inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
IL140433A0 (en) 1998-07-15 2002-02-10 Jomaa Hassan Phosphorous organic compounds and their use
US6303764B1 (en) 1998-09-24 2001-10-16 Zymetx, Inc. Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
US6664235B1 (en) 1999-08-20 2003-12-16 Riken Medicaments comprising sialic acid derivatives as active ingredients
US6420552B1 (en) 1999-09-10 2002-07-16 Zymetx, Inc. Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids
AU2039301A (en) * 1999-10-19 2001-04-30 Abbott Laboratories Neuraminidase inhibitors
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
CA2895884C (en) 2000-03-06 2019-04-23 University Of Kentucky Research Foundation A compound that selectively binds to cd123 and use thereof to kill hematologic cancer progenitor cells
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US20030096281A1 (en) * 2001-09-14 2003-05-22 Ganesh Venkataraman Methods of making glycomolecules with enhanced activities and uses thereof
JP2006241024A (ja) * 2005-03-01 2006-09-14 Takashi Suzuki 新規シアル酸誘導体
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN100471848C (zh) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 一组长链烷氧烷基取代唾液酸衍生物及其制备方法
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
JP5345073B2 (ja) 2007-01-23 2013-11-20 テラピコン エス．アール．エル． 抗ウイルス化合物
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US7981930B2 (en) * 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
CA2682738A1 (en) 2007-04-16 2008-10-23 Momenta Pharmaceuticals, Inc. Defined glycoprotein products and related methods
US7888337B2 (en) 2007-08-31 2011-02-15 Academia Sinica Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
WO2009129305A2 (en) 2008-04-15 2009-10-22 Tsrl, Inc. Prodrugs of neuraminidase inhibitors
DK2318832T3 (da) 2008-07-15 2014-01-20 Academia Sinica Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder
ES2507492T3 (es) 2008-11-28 2014-10-15 Cipla Limited Proceso para preparar zanamivir e intermedios para uso en el proceso
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
EP2228054A1 (en) 2009-03-13 2010-09-15 ITALFARMACO S.p.A. Riluzole aqueous suspensions
EP2427446B1 (en) * 2009-05-04 2016-03-30 National Research Council of Canada Inhibitors of sialidase or sialidase-like enzymes
CA2762022A1 (en) * 2009-05-15 2010-11-18 Redx Pharma Limited Redox drug derivatives
WO2011006237A1 (en) * 2009-07-15 2011-01-20 The University Of British Columbia 2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals
MX2012000576A (es) * 2009-07-16 2012-07-20 Univ Griffith Agentes anti-influenza.
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
JP2011136964A (ja) * 2009-12-28 2011-07-14 Gifu Univ ノイラミン酸誘導体、シアリダーゼ活性阻害剤及び抗インフルエンザ薬
CN102869784A (zh) 2010-04-07 2013-01-09 动量制药公司 高甘露糖聚糖
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
EP2568976B1 (en) * 2010-05-10 2015-09-30 Academia Sinica Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
CN101921251B (zh) * 2010-09-21 2011-10-05 仙居县圃瑞药业有限公司 扎那米韦中间体的精制工艺方法
CN102464640A (zh) * 2010-10-29 2012-05-23 江苏正大天晴药业股份有限公司 扎那米韦的制备方法
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
EP2678324A1 (en) 2011-02-24 2014-01-01 Cadila Healthcare Limited Process for the preparation of zanamivir
EP2686671A4 (en) 2011-03-12 2015-06-24 Momenta Pharmaceuticals Inc N-GLYCANES CONTAINING N-ACETYLHEXOSAMINE IN GLYCOPROTEIN PRODUCTS
WO2012142492A2 (en) * 2011-04-15 2012-10-18 University Of Georgia Research Foundation, Inc. Methods for inhibiting virus replication
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
WO2013093458A2 (en) 2011-12-21 2013-06-27 Redx Pharma Limited Antiviral drug derivatives
WO2013106937A1 (en) 2012-01-19 2013-07-25 The University Of British Columbia 3' equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2013181575A2 (en) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to denosumab
EP2885311B1 (en) 2012-08-18 2020-01-01 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
AU2013340559B2 (en) 2012-10-29 2018-03-15 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
EP2855533A4 (en) 2013-03-15 2015-11-25 Momenta Pharmaceuticals Inc METHODS RELATING TO CTLA4-FC FUSION PROTEINS
US10464996B2 (en) 2013-05-13 2019-11-05 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
EP3013347B1 (en) 2013-06-27 2019-12-11 Academia Sinica Glycan conjugates and use thereof
CN103396957B (zh) * 2013-07-11 2015-08-19 中国海洋大学 一种来源于鲤链霉菌的海洋微生物多糖及其制备方法
KR102298172B1 (ko) 2013-09-06 2021-09-06 아카데미아 시니카 변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화
CN104418876B (zh) * 2013-09-09 2019-05-17 中国科学院上海有机化学研究所 扎那米韦和拉那米韦的中间体及其合成方法
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
CA2937123A1 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
CN106415244B (zh) 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
KR20170003673A (ko) 2014-05-12 2017-01-09 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 감염성 질환을 치료하기 위한 다니릭신을 포함하는 약제 조성물
EP3149045B1 (en) 2014-05-27 2023-01-18 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
WO2015184002A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-her2 glycoantibodies and uses thereof
KR20220151036A (ko) 2014-05-27 2022-11-11 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
WO2015184001A1 (en) 2014-05-28 2015-12-03 Academia Sinica Anti-tnf-alpha glycoantibodies and uses thereof
NL2013420B1 (en) * 2014-09-05 2016-09-27 Univ Griffith Antiviral agents and uses thereof.
JP6899321B2 (ja) 2014-09-08 2021-07-07 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 糖脂質を使用するヒトｉＮＫＴ細胞活性化
WO2016063969A1 (ja) 2014-10-24 2016-04-28 ペプチドリーム株式会社 ヘマグルチニン結合ペプチド
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
CA2972072A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
WO2017156192A1 (en) 2016-03-08 2017-09-14 Academia Sinica Methods for modular synthesis of n-glycans and arrays thereof
TWI764917B (zh) 2016-08-22 2022-05-21 醣基生醫股份有限公司 抗體、結合片段及使用方法
CN106520864A (zh) * 2016-09-28 2017-03-22 南京农业大学 一种酶法合成唾液酸类似物的方法及其应用
WO2018213933A1 (en) * 2017-05-25 2018-11-29 The Governors Of The University Of Alberta Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
WO2023118896A1 (en) 2021-12-23 2023-06-29 Subintro Limited Novel antiviral compositions comprising oleic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE627295A (sv) 1962-01-18

Also Published As

Publication number Publication date
BG62092B1 (bg) 1999-02-26
CS114591A3 (en) 1991-12-17
KR0169496B1 (ko) 1999-01-15
CN1184108A (zh) 1998-06-10
SK282950B6 (sk) 2003-01-09
NO302751B1 (no) 1998-04-20
HK1010191A1 (en) 1999-06-17
PL167630B1 (pl) 1995-10-31
GR3026225T3 (en) 1998-05-29
MY107843A (en) 1996-06-29
WO1991016320A1 (en) 1991-10-31
AP9100253A0 (en) 1991-04-30
IE980526A1 (en) 2003-10-15
DE69133604D1 (de) 2008-10-09
JP2944750B2 (ja) 1999-09-06
PT97460A (pt) 1992-01-31
FI20001231A (sv) 2000-05-23
CA2081356A1 (en) 1991-10-25
CA2291994A1 (en) 1991-10-25
FI105478B (sv) 2000-08-31
NL990030I2 (nl) 2000-02-01
UA41252C2 (uk) 2001-09-17
AU654815B2 (en) 1994-11-24
HU219355B (en) 2001-03-28
YU48741B (sh) 1999-09-27
HUT61989A (en) 1993-03-29
EP0786458A2 (en) 1997-07-30
CA2291994C (en) 2003-10-14
FI924790A0 (fi) 1992-10-22
NL990030I1 (nl) 1999-12-01
NO974670D0 (no) 1997-10-09
FI924790A (fi) 1992-10-22
ES2313730T3 (es) 2009-03-01
SI9110745A (en) 1997-04-30
CZ288492B6 (en) 2001-06-13
US5648379A (en) 1997-07-15
NO1999021I1 (no) 1999-09-17
CN1091594C (zh) 2002-10-02
NO923944D0 (no) 1992-10-09
HU9203180D0 (en) 1992-12-28
EP0786458B1 (en) 2008-08-27
ES2113881T3 (es) 1998-05-16
IE911372A1 (en) 1991-11-06
EP0526543A4 (en) 1993-04-21
CY2186B1 (en) 2002-11-08
DK0526543T3 (da) 1998-08-24
BG96978A (bg) 1993-12-24
YU74591A (sh) 1994-06-24
CN1057260A (zh) 1991-12-25
DE69128469T2 (de) 1998-06-04
CN1150020A (zh) 1997-05-21
SI9110745B (en) 2001-06-30
NZ237936A (en) 1997-08-22
HK1003834A1 (en) 1998-11-06
ATE161253T1 (de) 1998-01-15
DE19975068I2 (de) 2002-10-10
EP0526543A1 (en) 1993-02-10
DE69128469D1 (de) 1998-01-29
HU210717A9 (en) 1995-06-28
CN1143853C (zh) 2004-03-31
EP0526543B1 (en) 1997-12-17
CN1036849C (zh) 1997-12-31
PL167192B1 (pl) 1995-08-31
NO923944L (no) 1992-12-18
OA09679A (en) 1993-05-15
PL166918B1 (pl) 1995-07-31
EP0786458A3 (en) 1999-10-13
US5360817A (en) 1994-11-01
AU7759091A (en) 1991-11-11
PT97460B (pt) 1999-01-29
ATE406358T1 (de) 2008-09-15
NO974670L (no) 1992-12-18
LU90468I2 (fr) 2000-01-03
ZA913086B (en) 1992-12-30
AP249A (en) 1993-03-17
JPH05507068A (ja) 1993-10-14
DE19975068I1 (de) 2000-01-13
AU7533891A (en) 1991-12-12
CA2081356C (en) 2000-02-22
RU2119487C1 (ru) 1998-09-27
SG43170A1 (en) 1997-10-17

Similar Documents

Publication Publication Date Title
AU654815B2 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents
EP0539204B1 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid
US5919819A (en) Dihydropyran derivatives as viral neuraminidase inhibitors
WO1995020583A1 (en) Derivatives of 2-deoxy-2,3-dehydro-n-acetylneuraminic acid (dana)
US5990156A (en) 6-Carboxamido dihydropyran derivatives
Masuda et al. Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives
WO1995018800A1 (en) Derivatives of 2-deoxy-2,3-dehydro-n-acetylneuraminic acid (dana)
US5639786A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
WO1996004265A1 (en) 2,6-DIDEOXY-2,3-DIDEHYDRO-6-THIO DERIVATIVES OF α-D-NEURAMINIC ACID
JP3923081B6 (ja) ウイルスノイラミニダーゼ阻害剤としてのジヒドロピラン誘導体

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
PEL Intention of commissioner to extend period of protection
EXTG Extension of patent term granted
KB Patent renewed
EXTN Extension order renewed
EXTN Extension order renewed